1999 ISNS Conference
Neo Gen Screening and Cambridge Isotopes presented screening services and products at the International Newborn Screening Conference in Stockholm, Sweden. There was clear emphasis at the meeting on Tandem Mass Spectrometry and Newborn Screening for which Neo Gen Screening is a pioneer. We presented information on our screening programs which includes both Comprehensive and Supplemental Newborn Screening, Stable Isotope Internal Standards for Newborn Screening by Tandem Mass Spectrometry, International Screening Partners, Demographic Information on our Screening Populations, and Information on Disease Frequency for the more than 700,000 newborns that have been tested by our program. By all measures our scientific and product presentations were a success and well received. Below is a photograph from the meeting and a listing of presentation by the Neo Gen Screening Staff.
PRESENTATIONS
Oral Presentations:
DH Chace and EW Naylor, Laboratory Integration and Utilization of Tandem Mass Spectrometry in Neonatal Screening: A model for Clinical Chemistry in the Next Millenium.
EW Naylor and DH Chace, Results of Routine Screening of over 600,000 Newborns for Inherited Metabolic Disorders Using Automated Electrospray Tandem Mass Spectrometry
SF Dobrowolski, EW Naylor, R Banas and D Thakkar, DNA Chip Technology and Neonatal Screening
Poster Presentations:
SF Dobrowolski, N Gregersen, B Andresen, R Banas, DH Chace, EW Naylor, Molecular analysis of the MCAD gene and its necessity for accurate newborn screening.
Workshops
DH Chace, Workshop on Tandem Mass Spectrometry. The Use of Stable Isotopes.
For more information and to receive our service brochures:
please write 
or us at:
[Home] [Info] [News] [Sales] [R&D] [Staff] [Results]